RE:Large BIOPHARMA 1.7 Trillion in dealmaking firepower.There have been a few multi- billion $ pharma deals lately. Reportedly more to come 2022.
a simple $billion for ONC = about $15 USD/ share.
or in Canadian $ closer to $18ps.
Those who have been around a long time see anything under $25ps++ as less than a good price.
The newbies & recent traders getting all excited over a few dimes, have no idea of Oncs real potential.
And, few would see anything over $5 as amazing!
take a step back _ wider longer view.
The most conservative analysts has projections, of $6ps.
most optimistic being $15ps
All of which are based o; assumptions of getting Pelareorep to market & not a complete take over.
using my nerves of steel, I bought more last week. Averaging down.
The end is near for this very long wait.
byuout, partnership or something elese Will b3 resolved June of 2022 at the latest.
They have $ until early 2023, but need 12 months of operating $ to satisfy listings & regulators.
With A.N. Stating phase 3 to start first 1/2 of 2022. Onc is under both financial & operating pressure to be in the same window.
hence m6 mid year deadline.